During the 2-year follow-up, periodically monitored imaging examinations and alpha-fetoprotein diagnosed 2 ETV-treated patients with HCC after more than 6-month drug treatment, one of whom had LC at baseline. This evidence concerns the gene AFP and hepatocellular carcinoma.